Financhill
Back

Amphastar Pharmaceuticals 10K Form

Buy
63

AMPH
Amphastar Pharmaceuticals

Last Price:
30.19
Seasonality Move:
5.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AMPH News And Ratings

See the #1 stock for the next 7 days that we like better than AMPH

AMPH Financial Statistics

Sales & Book Value

Annual Sales: $437.77M
Cash Flow: $14.75M
Price / Cash Flow: 17.5
Annual Sales: $10.39
Price / Book: 2.89

Profitability

EPS (TTM): 1.49000
Net Income (TTM): $77.23M
Gross Margin: $199.74M
Return on Equity: 16.37%
Return on Assets: 11.07%

Amphastar Pharmaceuticals Earnings Forecast

Key Amphastar Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 19 years for AMPH is 45.63%.
  • The Selling, General & Administrative Expenses for AMPH have been equal to 15.74% of Gross Profit Margin.
  • The Research & Development expenses have been 13.92% of Revenue.
  • The Interest Expense is 1.43% of Operating Income.
  • The Net Earning history of AMPH is 14.19% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 8 years.

Amphastar Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Current Symbol: AMPH
CUSIP: 03209R
Website: amphastar.com

Debt

Debt-to-Equity Ratio: 0.15
Current Ratio: 3.76
Quick Ratio: 2.67

Price-to-Earnings

Trailing P/E Ratio: 24.17
Forward P/E Ratio: 16.49

AMPH Technical Analysis vs Fundamental Analysis

Buy
63
Amphastar Pharmaceuticals (AMPH) is a Buy

Is Amphastar Pharmaceuticals a Buy or a Sell?